ACM
Asymmetry Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,979
| Closed | -$1.92M | – | 33 |
|
|
2021
Q2 | $1.92M | Buy |
+2,979
| New | +$1.92M | 1.32% | 23 |
|
|
2020
Q3 | – | Sell |
-6,434
| Closed | -$2.91M | – | 35 |
|
|
2020
Q2 | $2.91M | Sell |
6,434
-6,242
| -49% | -$2.82M | 2.23% | 18 |
|
|
2020
Q1 | $4.44M | Buy |
12,676
+6,325
| +100% | +$2.22M | 4.86% | 7 |
|
|
2019
Q4 | $2.35M | Buy |
6,351
+713
| +13% | +$264K | 4.21% | 9 |
|
|
2019
Q3 | $1.88M | Buy |
+5,638
| New | +$1.88M | 4.02% | 11 |
|
|
2019
Q1 | – | Sell |
-1,745
| Closed | -$405K | – | 26 |
|
|
2018
Q4 | $405K | Buy |
+1,745
| New | +$405K | 1.12% | 21 |
|
|
2018
Q3 | – | Sell |
-5,918
| Closed | -$1.71M | – | 36 |
|
|
2018
Q2 | $1.71M | Buy |
5,918
+1,407
| +31% | +$406K | 1.68% | 22 |
|
|
2018
Q1 | $1.13M | Sell |
4,511
-9,283
| -67% | -$2.32M | 1.41% | 26 |
|
|
2017
Q4 | $3.29M | Sell |
13,794
-6,448
| -32% | -$1.54M | 4.47% | 8 |
|
|
2017
Q3 | $4.5M | Sell |
20,242
-127
| -0.6% | -$28.2K | 5.22% | 7 |
|
|
2017
Q2 | $4.61M | Sell |
20,369
-2,344
| -10% | -$531K | 5.47% | 6 |
|
|
2017
Q1 | $4.53M | Buy |
22,713
+4,395
| +24% | +$876K | 6.31% | 6 |
|
|
2016
Q4 | $3.34M | Sell |
18,318
-12,369
| -40% | -$2.25M | 6.21% | 8 |
|
|
2016
Q3 | $5.03M | Sell |
30,687
-342
| -1% | -$56K | 8.74% | 3 |
|
|
2016
Q2 | $4.44M | Buy |
31,029
+18,979
| +158% | +$2.71M | 8.13% | 4 |
|
|
2016
Q1 | $1.65M | Buy |
+12,050
| New | +$1.65M | 4.29% | 11 |
|